Melink T - Search Results

1

Phase I trial of echinomycin (NSC 526417), a bifunctional intercalating agent, administered by 24-hour continuous infusion.

Kuhn JG, Von Hoff DD, Hersh M, Melink T, Clark GM, Weiss GR, Coltman CA. Kuhn JG, et al. Among authors: melink t. Eur J Cancer Clin Oncol. 1989 May;25(5):797-803. doi: 10.1016/0277-5379(89)90123-5. Eur J Cancer Clin Oncol. 1989. PMID: 2737217

2

Phase I trial and biochemical evaluation of tiazofurin administered on a weekly schedule.

Melink TJ, Sarosy G, Hanauske AR, Phillips JL, Bayne JH, Grever MR, Jayaram HN, Von Hoff DD. Melink TJ, et al. Sel Cancer Ther. 1990 Spring;6(1):51-61. doi: 10.1089/sct.1990.6.51. Sel Cancer Ther. 1990. PMID: 2343202

3

Phase I clinical investigation of amonafide.

Saez R, Craig JB, Kuhn JG, Weiss GR, Koeller J, Phillips J, Havlin K, Harman G, Hardy J, Melink TJ, et al. Saez R, et al. Among authors: melink tj. J Clin Oncol. 1989 Sep;7(9):1351-8. doi: 10.1200/JCO.1989.7.9.1351. J Clin Oncol. 1989. PMID: 2549205 Clinical Trial.

4

Phase I clinical trial of carbetimer.

Hanauske AR, Melink TJ, Harman GS, Clark GM, Craig JB, Koeller JM, Boldt DH, Kantor B, Kisner DL, Orczyk G, et al. Hanauske AR, et al. Among authors: melink tj. Cancer Res. 1988 Sep 15;48(18):5353-7. Cancer Res. 1988. PMID: 2842047

5

Phase I evaluation and pharmacokinetics of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193).

Melink TJ, Von Hoff DD, Kuhn JG, Hersh MR, Sternson LA, Patton TF, Siegler R, Boldt DH, Clark GM. Melink TJ, et al. Cancer Res. 1985 Jun;45(6):2859-65. Cancer Res. 1985. PMID: 3986813

6

The impact of phase I clinical trials on the quality of life of patients with cancer.

Melink TJ, Clark GM, Von Hoff DD. Melink TJ, et al. Anticancer Drugs. 1992 Dec;3(6):571-6. doi: 10.1097/00001813-199212000-00003. Anticancer Drugs. 1992. PMID: 1288727

7

Phase I trial of chloroguinoxaline sulfonamide, with correlation of its pharmacokinetics and pharmacodynamics.

Conley BA, O'Hara S, Wu S, Melink TJ, Parnes H, Pardoe E, Egorin MJ, Van Echo DA. Conley BA, et al. Among authors: melink tj. Cancer Chemother Pharmacol. 1995;37(1-2):139-49. doi: 10.1007/BF00685641. Cancer Chemother Pharmacol. 1995. PMID: 7497583 Clinical Trial.

8

Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses.

Redfern CH, Guthrie TH, Bessudo A, Densmore JJ, Holman PR, Janakiraman N, Leonard JP, Levy RL, Just RG, Smith MR, Rosenfelt FP, Wiernik PH, Carter WD, Gold DP, Melink TJ, Gutheil JC, Bender JF. Redfern CH, et al. Among authors: melink tj. J Clin Oncol. 2006 Jul 1;24(19):3107-12. doi: 10.1200/JCO.2005.04.4289. Epub 2006 Jun 5. J Clin Oncol. 2006. PMID: 16754937 Clinical Trial.

9

Interferon-alpha therapy of renal cancer.

Neidhart JA, Gagen MM, Young D, Tuttle R, Melink TJ, Ziccarrelli A, Kisner D. Neidhart JA, et al. Among authors: melink tj. Cancer Res. 1984 Sep;44(9):4140-3. Cancer Res. 1984. PMID: 6378379 Clinical Trial.

10

Planning and implementing clinical trials.

Melink TJ, Whitacre MY. Melink TJ, et al. Semin Oncol Nurs. 1991 Nov;7(4):243-51. doi: 10.1016/0749-2081(91)90062-t. Semin Oncol Nurs. 1991. PMID: 1775774

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters